Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn't make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.
A House ethics panel said it would continue its own probe after the Office of Congressional Ethics concluded that much of the trip appears "to have been undertaken for personal purposes, with only incidental, if any, campaign-related benefit," according to the report.
Purdue University will hold off on raising employees' salaries and changing job classifications in the wake of a last-minute suspension on a federal rule that would have expanded the pool of workers eligible for overtime pay.
The phone call drew an irritated response from China, whose foreign minister called the contact a "small trick by Taiwan" and noted that "healthy" U.S.-China relations hinge upon the so-called "one-China" policy.
The Indianapolis-based developer has narrowed its focus to industrial and medical-office properties. It's been selling off traditional office buildings, which used to make up the bulk of its portfolio.